SANTA CLARA, Calif.--(BUSINESS WIRE)--EndoClot Plus, Inc. (EPI), a privately held medical device company announced the FDA 510(k) clearance of EndoClot ® Submucosal Injection Agent (EndoClot ® SIA) ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--EndoClot Plus, Inc., a privately held medical device company founded by surgeons and biomaterial scientists announces the CE approval of EndoClot ® Adhesive ...
RICHMOND HILL, ON, April 8, 2025 /CNW/ -- Olympus Canada Inc. (OCI) announced today the expansion of Olympus' commercial partnership with EndoClot® Plus, Inc. (EPI) to include distribution of EndoClot ...
Olympus Europa SE & Co. KG is launching three Endoclot products, two hemostatic agents and a submucosal injection agent, in the Europe, Middle East and Africa (EMEA) region. This new portfolio was ...
"We are excited to expand our global partnership with EndoClot Plus, Inc. The addition of their solutions to our portfolio allows us to strengthen our commitment to our customers as a full ...
EndoClot PHS is a single-use device consisting of a starch-based powder hemostat to control bleeding in the GI tract. The Food and Drug Administration (FDA) has approved EndoClot ® Polysaccharide ...
Olympus Europa SE & Co. KG is launching three Endoclot products, two hemostatic agents and a submucosal injection agent, in the Europe, Middle East and Africa (EMEA) region. This new portfolio was ...
EndoClot Adhesive is a single-use medical device used to seal lesions, consisting of Adhesive Hemostatic Polymer (AHP) and an applicator to deliver the synthetic polymer to a lesion within the ...
Partnership will usher in new clinically differentiated solutions for the GI market while further strengthening Olympus' leadership in hemostasis, EMR and ESD CENTER VALLEY, Pa., April 4, 2022 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results